Mona Ståhle is a Professor at the Dermatology and Venereology Unit, Department of Medicine at the Karolinska Institutet in Stockholm, Sweden.
Mona Ståhle received her MD from the University of Lund. She became a specialist in Dermatology and Venerology at the Karolinska Hospital in 1984 and completed her PhD at the Karolinska Institutet (KI) in 1989. Between 1989 and 1991, she was a post-doctoral fellow at the Washington University, St Louis, United States, where she studied molecular biology, focusing on matrix metalloproteinases (MMP) in the skin. After returning to KI, she continued and expanded on this research in her laboratory. During this time, she started a company within Karolinska development aiming to develop a treatment for chronic wounds. The project is now with the Promore Pharma company, registered on the stock market in 2017, and the clinical trial program is continued.
In 1999 she became a professor of Dermatology and chair at the Dermatology Unit, Department of Medicine. For the past 20 years, the focus has been on immunogenetics and epidemiology of Psoriasis, building a research platform for translational studies at Karolinska, Stockholm. Patient cohorts are followed in local registries, and biobank material is used for research.